Insulet | PODD - Current Liabilities

Stock Price
256.62
Daily Change
0.81 0.32%
Monthly
-9.48%
Yearly
-7.99%
Q1 Forecast
247.93

Insulet reported $647.7M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Align Technology USD 1.97B 29.02M Sep/2025
AtriCure USD 77.84M 9M Sep/2025
Avanos Medical USD 147.9M 13.3M Sep/2025
Baxter International USD 3.78B 836M Sep/2025
Becton, Dickinson and Co. USD 8.31B 153M Sep/2025
Boston Scientific USD 5.33B 138M Sep/2025
Cardinal Health USD 40.27B 1.37B Sep/2025
Cooper Companies USD 1.11B 102.7M Sep/2025
Dexcom USD 3.34B 27.3M Sep/2025
Edwards Lifesciences USD 1.59B 183.3M Sep/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Globus Medical USD 465.96M 41.29M Sep/2025
ICU Medical USD 492.9M 10.12M Sep/2025
Insulet USD 647.7M 362.4M Sep/2025
Integra LifeSciences USD 364.05M 565.75M Sep/2025
J&J USD 50.87B 3.31B Sep/2025
Masimo USD 369.7M 222.4M Sep/2025
Medtronic USD 11.53B 1.35B Jun/2025
Merit Medical Systems USD 230.48M 4.9M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Solventum Corp USD 2.94B 318M Sep/2025
Stryker USD 7.79B 380M Dec/2025
Tandem Diabetes Care USD 252.54M 852K Sep/2025
Teleflex USD 773.03M 56.88M Sep/2025
West Pharmaceutical Services USD 635.4M 30.8M Sep/2025
Zimmer Biomet Holdings USD 2.4B 296.6M Sep/2025